Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12311010 | Formulated and/or co-formulated liposome compositions containing toll-like receptor(“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Bruce A. Hay, Tahmineh Safaie | 2025-05-27 |
| 12286403 | Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Bruce A. Hay, Tahmineh Safaie | 2025-04-29 |
| 12059470 | Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Bruce A. Hay, Tahmineh Safaie | 2024-08-13 |
| 11896646 | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Bruce A. Hay, Tahmineh Safaie | 2024-02-13 |
| 11833209 | Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Bruce A. Hay, Tahmineh Safaie | 2023-12-05 |
| 11801304 | Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Bruce A. Hay, Tahmineh Safaie | 2023-10-31 |
| 11744874 | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Bruce A. Hay, Tahmineh Safaie | 2023-09-05 |
| 11679141 | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Bruce A. Hay, Tahmineh Safaie | 2023-06-20 |